OMICS-based personalized oncology: if it is worth doing, it is worth doing well!

Overview of attention for article published in BMC Medicine, October 2013

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 189,459 followers.

RT @MedicalEvidence: Here's the @BMCMedicine Commentary on precision medicine just highlighted in the pragmatic trials session #ICTMC2017 h…

Here's the @BMCMedicine Commentary on precision medicine just highlighted in the pragmatic trials session #ICTMC2017 https://t.co/n99V7matR6

Our colleagues at @BMCMedicine have a couple of papers on omics in clinical oncology trials http://t.co/oJWVMBZB31 // http://t.co/j60rdH7OP0

Our colleagues at @BMCMedicine have a couple of papers on omics in clinical oncology trials http://t.co/oJWVMBZB31 // http://t.co/j60rdH7OP0

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.